Episodes
-
Episode 143: #JPM21: Déjà vu in Alzheimer's research, and OWS's legacy
Not summarized yet
-
Episode 142: Bob Nelsen on the pandemic's next phase, plus Biden's biopharma plans & a CES preview
Not summarized yet
-
Episode 141: Moderna's vaccine milestone, Warp Speed's hurdles, and biotech in 2021
Not summarized yet
-
Episode 140: Pfizer's Covid-19 vaccine — the debate, details, and distribution
Not summarized yet
-
Episode 139: Angela Rasmussen on AstraZeneca's confusing data, & Adam Koppel on biotech in 2021
Not summarized yet
-
Episode 138: The latest Covid-19 vaccine, Biden's pandemic plans, and Bill Gates unfiltered
Not summarized yet
-
Episode 137: Natalie Dean on Pfizer's Covid-19 vaccine, plus the FDA's Alzheimer's quandary
Not summarized yet
-
Bracing for a pandemic winter, Biogen's fortune at the FDA, and remembering a remarkable 12-year-old
Not summarized yet
-
Episode 135: Pfizer's Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5
Not summarized yet
-
Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's
Not summarized yet
-
Episode 133: A week of pauses, pharma’s statehouse spending, & how HBCUs approach Covid-19 trials
Not summarized yet
-
Episode 132: How Trump's case of Covid-19 affects biotech, medicine, and the FDA with George Scangos
Not summarized yet
-
Episode 131: Saad Omer on Covid-19 vaccine trials, & Ethan Weiss on intermittent fasting
Not summarized yet
-
Episode 130: A road map for Covid-19, the gold rush in health tech, & D.C.'s pandemic unrest
Not summarized yet
-
Episode 129: Heidi Tworek on pandemic PR, plus the CDC's credibility crisis & a lightning round
Not summarized yet
-
Episode 128: AstraZeneca’s Covid-19 vaccine, coronavirus politics, & STAT’s Health Tech Summit
Not summarized yet
-
Episode 127: Eric Topol on Stephen Hahn, plus Covid-19 vaccine timelines, & the 2000th First Opinion
Not summarized yet
-
Episode 126: The FDA's chaotic week, Trump's effect on science, and Musk's big reveal
Not summarized yet
-
Episode 125: Shocking FDA rejections, a longevity science setback & Derek Lowe on Covid-19 vaccines
Not summarized yet
-
Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies
Not summarized yet
Follow this show on AudioBrevity and new episodes get summarized for you. Create a free account